Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

September 30, 2011

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

September 27, 2011

Study Finds Vitamin B12 May Prevent Memory Loss
Experts used to think that cognitive decline was an inevitable part of aging, but a growing body of research is finding that lifestyle factors like exercising and a healthy diet may delay the process. A new study has found a link between poor nutrition and cognitive problems in older adults. The study, published Monday in the journal Neurology, found that adults over 65 with a vitamin B12 deficiency are more likely to have lower brain volumes and cognitive impairment than those with adequate B12.
Read article at foxnews.com (USA)

September 23, 2011

Omega-3 may ease depression symptoms, slash dementia risk: RCT
Fish oil supplements may reduce symptoms of depression and a subsequent risk of dementia, suggests new data from Australia.
Read article at nutraingredients.com

For more natural health news, click here.

See also our 2001-2010 news archive, by clicking here.

Pharma "Business with Disease" News

September 27, 2011

Common painkillers can raise heart risk
Taking daily doses of over-the-counter painkillers can increase the risk of heart attacks and stroke by up to 40 per cent, researchers have warned.
Read article in the Daily Telegraph (UK)

September 26, 2011

The Cost Of Treating Cancer Is ‘Unsustainable’
Thanks to a rising number of new meds and technologies, the price tags for accessing these salves and a growing number of patients, the cost of treating cancer is increasingly becoming unaffordable in many developed countries, according to a report commissioned by The Lancet Oncology journal.
Read article at pharmalot.com
Comment: The headline says it all. For almost a century, cancer has been the target of an investment business - the pharmaceutical industry - that has turned it into a multi-billion dollar business. The outcome was predictable: Today, at the beginning of the 21st Century, cancer is spreading globally; for most types of cancer the annual death rate still increases and the skyrocketing costs are financially ruining millions of cancer patients and strangulating the economies of entire nations. However, the publication of a new book, ‘Victory Over Cancer,’ by Dr. Rath and Dr. Niedzwiecki, marks the end of this tragedy. The natural health approaches presented in this book have been shown to block all key mechanisms that make cancer a deadly disease. Click here to learn more and read the book online.

September 26, 2011

Company stock prices before public announcements of oncology trial results
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal of the National Cancer Institute. Regulatory decisions made by the FDA and phase III clinical trials are important for the financial success of new drugs. Investors with information on the trial results and FDA decisions before they are released to the public may profit regardless of the drug's success or failure. This information can also influence the market value of the companies that bring the drugs to market. Trial investigators, company employees, and outside consultants are aware of trials results before they are made public, and investment analysts may go to great lengths to obtain this "insider information" for their clients because the results are not necessarily reflected in the market price of a stock.
Read article at medicalxpress.com
Comment: For anybody who is still in any doubt, this study provides further evidence that the drug industry is driven by the profits of its investors. To the men who control the ‘Business with Disease,’ it isn’t important how these profits are generated, simply that they are. As a result, profit and the accumulation of wealth are the main driving forces behind every decision taken.

September 21, 2011

Those Active Pharma Ingredients May Be Fishy
In recent years, studies have shown that active pharmaceutical ingredients were found in effluent coming from waste-water treatment plants near manufacturing plants. Now, a new study indicates that APIs were linked to changes in sexual characteristics of a type of fish in a river in France and, therefore, may have further damaging consequences on the larger ecosystem.
Read article at pharmalot.com

September 19, 2011

Chronic disease to cost $47 trillion by 2030, WEF says
Unless current health trends are reversed, five common, non-infectious diseases -- cancer, diabetes, heart disease, lung disease and mental health problems -- will cost the world $47 trillion in treatment costs and lost wages. That's the conclusion of a new report, "The Global Economic Burden of Non-communicable Diseases," released by the World Economic Forum before the start Monday of a two-day United Nations summit on non-communicable diseases, CBS News reported.
Read article in the USA Today newspaper
Comment: The publication of this report provides a timely reminder that chronic deficiencies of vitamins, amino acids and other specific micronutrients – the primary cause of today’s most common chronic diseases – are being deliberately ignored. The key beneficiary from the skyrocketing costs of chronic disease is the Pharmaceutical Investment “Business with Disease”. However, with the publication of Dr. Rath and Dr. Niedzwiecki’s new book, ‘Victory Over Cancer', the people of the world have another vital tool with which to act. With Dr. Rath already having shown that the “cardiovascular epidemic” is preventable, the publication of this latest book now paves the way towards turning cancer into a manageable disease.

For more pharma "business with disease" news, click here.

See also our 2001-2010 news archive, by clicking here.

GMO News

September 25, 2011

China says "no" to the commercialization of GE rice?
China's major financial weekly the Economic Observer quoted on Friday, Sept 23rd, 2011, an information source close to the Ministry of Agriculture that China has suspended the commercialization of genetically engineered (GE) rice.
Read article on the Greenpeace East Asia website

September 15, 2011

France retains ban on GM Maize despite EU Court opinion
The French government still refuses to lift its ban on growing genetically modified corn in France, despite the European Court of Justice saying that France's 2008 prohibition against Monsanto's MON810 variety was out of line on procedural grounds.
Read article at allaboutfeed.net

For more GMO news, click here.

See also our 2001-2010 news archive, by clicking here.

Other Health-related News

September 27, 2011

Low vitamin D levels may damage lungs, promote severe asthma: Study
Deficient levels of vitamin D may cause structural changes in the airways of children with a severe type of asthma, suggests new data from London. Children with a form of asthma called severe therapy-resistant asthma (STRA) were more likely to have lower blood levels of vitamin compared with moderately asthmatic and non-asthmatic children, according to findings published in the American Journal of Respiratory and Critical Care Medicine.
Read article at nutraingredients-usa.com

September 23, 2011

Poor diet linked to teen mental health problems
Adolescents who eat unhealthily are more likely to develop mental health problems than those with good diets, a new study has found.
Read article at medicalxpress.com
Comment: Interviewed about this study, Dr. Tim Crowe, Associate Professor in Nutrition at Deakin University’s School of Exercise and Nutrition Sciences said: “The key concept of having a healthy diet is not only good for us physically and in preventing a range of diseases, it’s good for our brain as well. We know our brain needs a lot of nutrients to run and function and well. You are not going to get as many of those nutrients from a very nutrient-poor diet.”

September 22, 2011

Vitamin D deficiency linked with airway changes in children with severe asthma
Children with severe therapy-resistant asthma (STRA) may have poorer lung function and worse symptoms compared to children with moderate asthma, due to lower levels of vitamin D in their blood, according to researchers in London. Lower levels of vitamin D may cause structural changes in the airway muscles of children with STRA, making breathing more difficult.
Read article at medicalxpress.com

September 19, 2011

NGO demands resignation of EFSA officials
New research has revealed "further conflicts of interest" among experts advising the European Food Safety Authority (EFSA) about the safety of food additives. A study found that two of the new experts appointed by EFSA to the panel responsible for looking at food additives have allegedly failed to declare consulting activities for the food industry-funded think tank and lobby group, International Life Sciences Institute (ILSI).
Read article at theparliament.com

For more health-related news, click here.

See also our 2001-2010 news archive, by clicking here.

Political News

September 26, 2011

Blair the envoy 'pushed deals worth billions' for investment bank that pays him £2m a year
Tony Blair is facing fresh questions over his role as a Middle East peace envoy after claims that he has used the position to promote lucrative business deals for clients of an investment bank that pays him £2million a year. As a representative of the Quartet –the UN, the EU, the U.S. and Russia – the former prime minister is tasked with fostering peace between Israel and Palestine. But he has also used the post to promote two contracts worth more than £1billion in Palestine with British Gas and mobile phone firm Wataniya – both major clients of JP Morgan, the U.S. investment bank which employs him as a senior adviser.
Read article in the Daily Mail (UK)
Comment: For information on the history of JP Morgan, and its relationship to the Rockefeller family and the Investment 'Business With Disease', click here.

September 20, 2011

Welcome to Boston, Mr. Rumsfeld. You Are Under Arrest.
Former Secretary of Defense Donald Rumsfeld has been stripped of legal immunity for acts of torture against US citizens authorized while he was in office. The 7th Circuit made the ruling in the case of two American contractors who were tortured by the US military in Iraq after uncovering a smuggling ring within an Iraqi security company. The company was under contract to the Department of Defense. The company was assisting Iraqi insurgent groups in the "mass acquisition" of American weapons. The ruling comes as Rumsfeld begins his book tour with a visit to Boston on Wednesday, September 21, and as new, uncensored photos of Abu Ghraib spark fresh outrage across Internet. Awareness is growing that Bush-era crimes went far beyond mere waterboarding.
Read article at alternet.org

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website. Citizens of the UK can find additional UK-orientated news stories on the Reject the EU website.

 

Back to the Newsletter Archive…